Elanco Animal Health (5EA) Stock Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

5EA Analyst Ratings

Strong Buy

10 Buy

1 Hold

0 Sell

Based on 11 analysts giving stock ratings to

Elanco

Animal Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

5EA Stock 12 Month Forecast

Average Price Target

€26.00

▲(34.15% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Elanco Animal Health in the last 3 months. The average price target is €26.00 with a high forecast of €28.00 and a low forecast of €20.12. The average price target represents a 34.15% change from the last price of €19.38.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"€10","19":"€19","28":"€28","14.5":"€14.5","23.5":"€23.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":27.99774976,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€28.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25.99791049142857,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€26.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20.12338264,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€20.12</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,14.5,19,23.5,28],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.2,21.722903827692306,22.245807655384613,22.768711483076924,23.29161531076923,23.814519138461538,24.337422966153845,24.860326793846156,25.383230621538463,25.90613444923077,26.429038276923077,26.951942104615384,27.474845932307694,{"y":27.99774976,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.2,21.5690700378022,21.938140075604394,22.307210113406594,22.67628015120879,23.04535018901099,23.414420226813185,23.783490264615384,24.15256030241758,24.52163034021978,24.890700378021975,25.259770415824175,25.628840453626374,{"y":25.99791049142857,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.2,21.11718328,21.03436656,20.95154984,20.868733119999998,20.785916399999998,20.703099679999998,20.62028296,20.53746624,20.45464952,20.3718328,20.28901608,20.20619936,{"y":20.12338264,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":12.222,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.91,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.634,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.748,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.484,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.876,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.462,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.625,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.05,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.5,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.345,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.26,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.2,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€28.00

Average Price Target€26.00

Lowest Price Target€20.12

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David Westenberg

Piper Sandler

€26.25

Buy

35.44%

Upside

Reiterated

06/29/26

Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (NASDAQ: ACAD), Elanco Animal Health (NYSE: ELAN) and Bristol-Myers Squibb (NYSE: BMY)

Jasper Hellweg

Argus Research

―

Buy

―

Reiterated

06/23/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Steve Scala

TD Cowen

€27.12→€28

Buy

44.47%

Upside

Assigned

06/18/26

Elanco Upgraded to Buy on Blockbuster Product Cycle, Robust Pipeline, and Higher Price Target Outlook

Glen Santangelo

Barclays

€26.25

Buy

35.44%

Upside

Reiterated

06/11/26

Barclays Reaffirms Their Buy Rating on Elanco Animal Health (ELAN)

Michael Ryskin

Bank of America Securities

€28

Buy

44.47%

Upside

Reiterated

06/05/26

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN), Pharma Mar SA (Other OTC: PHMMF) and Sotera Health (NASDAQ: SHC)

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

06/03/26

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and Kazia Therapeutics (NASDAQ: KZIA)

Erin Wright

Morgan Stanley

€20.12

Hold

3.84%

Upside

Reiterated

06/02/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Elanco Animal Health (NYSE: ELAN), AbSci (NASDAQ: ABSI) and Travere Therapeutics (NASDAQ: TVTX)

Jonathan Block

Stifel Nicolaus

―

Buy

―

Reiterated

05/22/26

Analysts Offer Insights on Healthcare Companies: Bioventus (NASDAQ: BVS) and Elanco Animal Health (NYSE: ELAN)

Umer Raffat

Evercore ISI

―

Buy

―

Reiterated

05/11/26

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH), Elanco Animal Health (NYSE: ELAN) and Align Tech (NASDAQ: ALGN)

Chris Schott

J.P. Morgan

€24.5→€26.25

Buy

35.44%

Upside

Assigned

05/07/26

Elanco price target raised to $30 from $28 at JPMorganElanco price target raised to $30 from $28 at JPMorgan

Daniel Grosslight

Citi

€26.25→€27.12

Buy

39.95%

Upside

Reiterated

05/07/26

Elanco price target raised to $31 from $30 at CitiElanco price target raised to $31 from $30 at Citi

Andrea Alfonso

UBS

€27.12

Buy

39.95%

Upside

Reiterated

03/10/26

Analysts Are Bullish on These Healthcare Stocks: Elanco Animal Health (ELAN), Eli Lilly & Co (LLY)

Unknown Analyst

Jefferies

Not Ranked

Jefferies

€26.25

Buy

35.44%

Upside

Reiterated

02/25/26

Jefferies Reaffirms Their Buy Rating on Elanco Animal Health (ELAN)

Scott Schoenhaus

KeyBanc

€23.62→€25.37

Buy

30.92%

Upside

Reiterated

02/25/26

KeyBanc Sticks to Its Buy Rating for Elanco Animal Health (ELAN)

Daniel Clark

Leerink Partners

€26.25

Buy

35.44%

Upside

Reiterated

02/24/26

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and Henry Schein (NASDAQ: HSIC)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David Westenberg

Piper Sandler

€26.25

Buy

35.44%

Upside

Reiterated

06/29/26

Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (NASDAQ: ACAD), Elanco Animal Health (NYSE: ELAN) and Bristol-Myers Squibb (NYSE: BMY)

Jasper Hellweg

Argus Research

―

Buy

―

Reiterated

06/23/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Steve Scala

TD Cowen

€27.12→€28

Buy

44.47%

Upside

Assigned

06/18/26

Elanco Upgraded to Buy on Blockbuster Product Cycle, Robust Pipeline, and Higher Price Target Outlook

Glen Santangelo

Barclays

€26.25

Buy

35.44%

Upside

Reiterated

06/11/26

Barclays Reaffirms Their Buy Rating on Elanco Animal Health (ELAN)

Michael Ryskin

Bank of America Securities

€28

Buy

44.47%

Upside

Reiterated

06/05/26

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN), Pharma Mar SA (Other OTC: PHMMF) and Sotera Health (NASDAQ: SHC)

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

06/03/26

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and Kazia Therapeutics (NASDAQ: KZIA)

Erin Wright

Morgan Stanley

€20.12

Hold

3.84%

Upside

Reiterated

06/02/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Elanco Animal Health (NYSE: ELAN), AbSci (NASDAQ: ABSI) and Travere Therapeutics (NASDAQ: TVTX)

Jonathan Block

Stifel Nicolaus

―

Buy

―

Reiterated

05/22/26

Analysts Offer Insights on Healthcare Companies: Bioventus (NASDAQ: BVS) and Elanco Animal Health (NYSE: ELAN)

Umer Raffat

Evercore ISI

―

Buy

―

Reiterated

05/11/26

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH), Elanco Animal Health (NYSE: ELAN) and Align Tech (NASDAQ: ALGN)

Chris Schott

J.P. Morgan

€24.5→€26.25

Buy

35.44%

Upside

Assigned

05/07/26

Elanco price target raised to $30 from $28 at JPMorganElanco price target raised to $30 from $28 at JPMorgan

Daniel Grosslight

Citi

€26.25→€27.12

Buy

39.95%

Upside

Reiterated

05/07/26

Elanco price target raised to $31 from $30 at CitiElanco price target raised to $31 from $30 at Citi

Andrea Alfonso

UBS

€27.12

Buy

39.95%

Upside

Reiterated

03/10/26

Analysts Are Bullish on These Healthcare Stocks: Elanco Animal Health (ELAN), Eli Lilly & Co (LLY)

Unknown Analyst

Jefferies

Not Ranked

Jefferies

€26.25

Buy

35.44%

Upside

Reiterated

02/25/26

Jefferies Reaffirms Their Buy Rating on Elanco Animal Health (ELAN)

Scott Schoenhaus

KeyBanc

€23.62→€25.37

Buy

30.92%

Upside

Reiterated

02/25/26

KeyBanc Sticks to Its Buy Rating for Elanco Animal Health (ELAN)

Daniel Clark

Leerink Partners

€26.25

Buy

35.44%

Upside

Reiterated

02/24/26

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and Henry Schein (NASDAQ: HSIC)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

BBOTBridgeBio Oncology Therapeutics

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

MLYSMineralys Therapeutics, Inc.

AMLXAmylyx Pharmaceuticals Inc

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Elanco Animal Health

3 Months

Steve ScalaTD Cowen

Success Rate

11/15 ratings generated profit

Average Return

+13.38%

Copying Steve Scala's trades and holding each position for 3 Months would result in 73.33% of your transactions generating a profit, with an average return of +13.38% per trade.

1 Year

Jonathan BlockStifel Nicolaus

Success Rate

21/25 ratings generated profit

Average Return

+35.95%

Copying Jonathan Block's trades and holding each position for 1 Year would result in 84.00% of your transactions generating a profit, with an average return of +35.95% per trade.

2 Years

Jonathan BlockStifel Nicolaus

Success Rate

24/25 ratings generated profit

Average Return

+57.12%

Copying Jonathan Block's trades and holding each position for 2 Years would result in 96.00% of your transactions generating a profit, with an average return of +57.12% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

5EA Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 5EA has received 12 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. 5EA average Analyst price target in the past 3 months is 26.00.

Each month's total comprises the sum of three months' worth of ratings.

5EA Financial Forecast

5EA Earnings Forecast

Next quarter’s earnings estimate for 5EA is €0.23 with a range of €0.22 to €0.25. The previous quarter’s EPS was €0.35. 5EA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year 5EA has Performed in-line its overall industry.

5EA Sales Forecast

Next quarter’s sales forecast for 5EA is €1.15B with a range of €1.13B to €1.16B. The previous quarter’s sales results were €1.20B. 5EA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year 5EA has Performed in-line its overall industry.

5EA Stock Forecast FAQ

What is DE:5EA’s average 12-month price target, according to analysts?

Based on analyst ratings, Elanco Animal Health’s 12-month average price target is 26.00.

What is DE:5EA’s upside potential, based on the analysts’ average price target?

Elanco Animal Health has 34.15% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Elanco Animal Health a Buy, Sell or Hold?

Elanco Animal Health has a consensus rating of Strong Buy, which is based on 10 buy ratings, 1 hold ratings and 0 sell ratings.

What is Elanco Animal Health’s share price target?

The average share price target for Elanco Animal Health is 26.00. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €28.00 ,and the lowest forecast is €20.12. The average share price target represents 34.15% Increase from the current price of €19.38.

What do analysts say about Elanco Animal Health?

Elanco Animal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of Elanco Animal Health?

To buy shares of DE:5EA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Elanco Animal Health (5EA) Stock Forecast & Price Target

5EA Analyst Ratings

5EA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Elanco Animal Health

5EA Analyst Recommendation Trends

5EA Financial Forecast

5EA Earnings Forecast

5EA Sales Forecast

5EA Stock Forecast FAQ

Detailed List of Analyst Forecasts